Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
76 - Can you please clarify if there are any differences in terms of the PAAB review of an NOC/c product vs a product with full NOC?
-
Health Canada has advised the PAAB to be cautious about approving advertising for products approved as Notice of Compliance with Conditions (NOC/C). There are some special conditions. Health Canada has approved the guideline that the PAAB has posted on the PAAB web-site https://www.paab.ca/Guidance_on_Advertising_for_Drugs_with_Notice_of_Compliance_with_Conditions_(NOCc)_Feb_2018_(typofix)_docx.pdf You can access that web page for full details.
